NCT04199897

Brief Summary

Dental caries is a non-communicable biofilm-mediated disease affecting both crown and exposed root surfaces in the primary and permanent dentitions. The carious process involves interactions between the biofilm formed on the tooth surface, sugars, salivary and genetic factors. Based on more than 100 years of research, there is unequivocal evidence that dietary fermentable carbohydrates (sugars and starch) play a key role in caries initiation and progression. In this context, sucrose deserves special attention; apart from being rapidly converted into acids it is also synthesized into extracellular glucans, fructans and intracellular storage compounds. According to the ecological plaque hypothesis, it is generally accepted that sucrose exposure is fueling and driving the stable and diverse symbiotic oral biofilm to a dysbiotic form with a reduced diversity and overgrowth of acidogenic and acid-tolerating species. Such typical bacterial profiles have demonstrated in subjects with different stages of caries in cross-sectional settings but the timing associated with a sugar provocations is less known. Moreover, the use of probiotic bacteria in adjunct to regular oral care to support biofilm diversity and prevent dental caries has gained momentum in recent years. It has been demonstrated that probiotic supplements can increase salivary pH, and reduce the counts of salivary S. mutans, thereby exert a stabilizing effect on the oral microbiota. In this context, it is of interest to explore whether or not the use of beneficial bacteria can counteract a sugar-driven shift in the salivary microbiota. Another question of interest is to study if the oral biofilm has a colonization memory similar to that of the gastro-intestinal tract and the suggested study design could possibly enlighten this area of research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 9, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 16, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

May 5, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2020

Completed
Last Updated

October 15, 2021

Status Verified

October 1, 2021

Enrollment Period

2 months

First QC Date

December 9, 2019

Last Update Submit

October 8, 2021

Conditions

Keywords

Dental CariesSalivary microbiotaProbiotics

Outcome Measures

Primary Outcomes (1)

  • Change in microbial diversity of salivary microbiota

    alpha-diversity (shannon-index)

    Baseline alpha-diversity vs. alpha-diversity at day 35

Secondary Outcomes (2)

  • Change in supragingival biofilm level

    Baseline plaque-index vs. plaque-index day 35

  • Change in gingival bleeding

    Baseline bleeding-index vs. bleeding-index day 35

Study Arms (4)

Intervention group (sucrose + probiotics)

EXPERIMENTAL

Sucrose rinsing 8 times a day for 14 days Probiotic lozenges 2 times a day for 25 days

Dietary Supplement: Succrose rinsingDietary Supplement: Probiotic lozenges

Intervention group (sucrose + placebo

ACTIVE COMPARATOR

Sucrose rinsing 8 times a day for 14 days Placebo lozenges 2 times a day for 25 days

Dietary Supplement: Succrose rinsingOther: Placebo tablets

Control group (xylitol + probiotics)

PLACEBO COMPARATOR

Xylitol rinsing 8 times a day for 14 days Probiotic lozenges 2 times a day for 25 days

Dietary Supplement: Probiotic lozengesOther: xylitol rinsing

Control group (xylitol + placebo

PLACEBO COMPARATOR

Xylitol rinsing 8 times a day for 14 days Placebo lozenges 2 times a day for 25 days

Other: xylitol rinsingOther: Placebo tablets

Interventions

Succrose rinsingDIETARY_SUPPLEMENT

Sucrose rinsing 7-8 times a day for 14 days

Intervention group (sucrose + placeboIntervention group (sucrose + probiotics)
Probiotic lozengesDIETARY_SUPPLEMENT

Probiotic lozenges 2 times a day for 35 days

Control group (xylitol + probiotics)Intervention group (sucrose + probiotics)

Xylitol rinsing 7-8 times a day for 14 days

Control group (xylitol + placeboControl group (xylitol + probiotics)

Placebo lozenges 2 times a day for 35 days

Control group (xylitol + placeboIntervention group (sucrose + placebo

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • more than 20 own natural teeth
  • no chronic systemic diseases affecting salivary functions
  • no medication except for contraceptives
  • non-smoker

You may not qualify if:

  • treatment requiring oral diseases i.e. dental caries, gingivitis and periodontitis
  • systemic antibiotics within the latest 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Copenhagen, Dept. of Odontology

Copenhagen, 2200, Denmark

Location

MeSH Terms

Conditions

Dental CariesGingivitis

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic DiseasesInfectionsGingival DiseasesPeriodontal DiseasesMouth Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Computerized randomization followed by pseudo anonymication
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The study will employ a randomized triple-blind, placebo controlled design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor, Principal Investiator, dr. odont., PhD, DDS

Study Record Dates

First Submitted

December 9, 2019

First Posted

December 16, 2019

Study Start

May 5, 2020

Primary Completion

June 30, 2020

Study Completion

June 30, 2020

Last Updated

October 15, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will not share

Locations